Prosecution Insights
Prosecution Insights
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (33%) |
| §112 only | 1 (33%) |
| No statute on record | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SONG, HOON K | 1 | 86.1% | +8.4% |
| MYERS, CARLA J | 1 | 48.6% | +47.0% |
| SWARTWOUT, BRIANNA KENDALL | 1 | 46.0% | +62.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17444778 | USE OF BMMF1 REP PROTEIN AS A BIOMARKER FOR BREAST CANCER | SWARTWOUT, BRIANNA KENDALL | 329d overdue |
| 17599681 | ARYL HYDROCARBON RECEPTOR (AHR) ACTIVATION SIGNATURE AND METHODS FOR DETERMINING AHR SIGNALING STATUS | MYERS, CARLA J | 22d overdue |
| Art Unit | Apps |
|---|---|
| 2884 | 1 |
| 1682 | 1 |
| 1644 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18833169 | APPARATUS FOR RADIOTHERAPY AND METHOD OF OPERATING AN APPARATUS FOR RADIOTHERAPY | SONG, HOON K | 2884 | Other | Non-Final OA | 1d overdue | Pending | Jul 25, 2024 |
| 17599681 | ARYL HYDROCARBON RECEPTOR (AHR) ACTIVATION SIGNATURE AND METHODS FOR DETERMINING AHR SIGNALING STATUS | MYERS, CARLA J | 1682 | §112 | Final Rejection | 22d overdue | Pending | Sep 29, 2021 |
| 17444778 | USE OF BMMF1 REP PROTEIN AS A BIOMARKER FOR BREAST CANCER | SWARTWOUT, BRIANNA KENDALL | 1644 | §102 | Non-Final OA | 329d overdue | Pending | Aug 10, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial